title: Clinical pharmacology of lasofoxifene in Japanese and white postmenopausal women.
authors.affiliation: Pfizer Global Research and Development, Eastern Point Road, Groton, CT 06341, USA. Robert.j.fountaine@pfizer.com
authors.forename: R J
authors.initials: RJ
authors.lastname: Fountaine
authors.forename: Y
authors.initials: Y
authors.lastname: Nishizawa
authors.forename: G
authors.initials: G
authors.lastname: Wei
authors.forename: L
authors.initials: L
authors.lastname: Dogolo
authors.forename: A
authors.initials: A
authors.lastname: Calcagni
authors.forename: M J
authors.initials: MJ
authors.lastname: Gardner
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D000469:Alkaline Phosphatase / Q000378:metabolism; D000596:Amino Acids / Q000378:metabolism; D044466:Asian People; D008076:Cholesterol, HDL / Q000378:metabolism; D008078:Cholesterol, LDL / Q000378:metabolism; D024042:Collagen Type I / Q000378:metabolism; D004311:Double-Blind Method; D005260:Female; D005640:Follicle Stimulating Hormone / Q000378:metabolism; D006801:Humans; D007986:Luteinizing Hormone / Q000378:metabolism; D008875:Middle Aged; D010455:Peptides / Q000378:metabolism; D017698:Postmenopause / Q000378:metabolism*; D011759:Pyrrolidines / Q000097:blood / Q000493:pharmacokinetics* / Q000494:pharmacology*; D020845:Selective Estrogen Receptor Modulators / Q000097:blood / Q000493:pharmacokinetics* / Q000494:pharmacology*; D013764:Tetrahydronaphthalenes / Q000097:blood / Q000493:pharmacokinetics* / Q000494:pharmacology*; D044465:White People
chemical_list: D000596:Amino Acids; D008076:Cholesterol, HDL; D008078:Cholesterol, LDL; D024042:Collagen Type I; D010455:Peptides; D011759:Pyrrolidines; D020845:Selective Estrogen Receptor Modulators; D013764:Tetrahydronaphthalenes; C052929:collagen type I trimeric cross-linked peptide; C111332:Lasofoxifene; D007986:Luteinizing Hormone; D005640:Follicle Stimulating Hormone; C036020:deoxypyridinoline; D000469:Alkaline Phosphatase